Resize text 
Resize text 
Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium is a collaborative European project that comprises a programme to address limitations of current methods in the field of pharmacoepidemiology and pharmacovigilance. The European Medicines Agency (EMA) is the coordinator of PROTECT and GSK is the deputy co-ordinator of PROTECT. They manage a multi-national consortium of 31 partners including academics, regulators, SMEs and EFPIA companies.
| Latest News | |
|---|---|
| 28 September 2011 | PROTECT Consortium Assembly The 2011 Consortium Assembly will take place on 24 October 2011 at the premises of the European Medicines Agency in London. The Assembly will review progress made during year 2 of the project. In addition, the second periodic project report and the budget for the forthcoming project year will be adopted. See also: Governance structure |
| 6 September 2011 | PROTECT - NEW journal publications PROTECT Work Package 2 (Framework for pharmacoepidemiology studies) publishes first results on balancing confounders using propensity score methods and selection of confounding variables for adjustment. For more information see: PROTECT Publications |
| 6 September 2011 | PROTECT at ICPE - abstracts now available online Several PROTECT researchers presented their results at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management which took place in August in Chicago. The abstracts have been published in Pharmacoepidemiology & Drug Safety. For more information see: Pharmacoepidemiology & Drug Safety (Volume 20, Issue Supplement S1) |
